Spasticity

FDA Approves Botulinum Toxin Injection for Pediatric Spasticity

FDA Approves Botulinum Toxin Injection for Pediatric Spasticity

By

The drug is the first botulinum toxin indicated for the treatment of lower limb spasticity in pediatric patients.

Updated Treatment Guidelines for the Use of Botulinum Toxin in Spasticity, Headache

Updated Treatment Guidelines for the Use of Botulinum Toxin in Spasticity, Headache

By

Treatment of chronic, but not episodic migraine with botulinum toxin has been added to the treatment guidelines.

Sign Up for Free e-newsletters



CME Focus